Christina Scherer

Christina Scherer is an accomplished professional in the field of biotechnology and pharmaceutical development, with extensive experience in early portfolio management. At Acrivon Therapeutics, Inc., Christina held multiple leadership roles from April 2022 to September 2024, including Vice President and Head of Early Portfolio Management. Prior to this, Christina served as Senior Director of Product and Portfolio Development at Anokion from September 2019 to March 2022, and held similar positions at Kanyos Bio and The Broad Institute, where responsibilities included directing anti-infectives discovery and managing program alliances. Christina Scherer earned a Bachelor of Arts degree in Biology from Amherst College and a PhD in Biology from the Massachusetts Institute of Technology.